Convalescent plasma for hospitalized patients with COVID-19 and the effect of plasma antibodies: a randomized controlled, open-label trial
The CONCOR-1 Study Group, CONCOR-1 writing committee, View ORCID ProfilePhilippe Bégin, View ORCID ProfileJeannie Callum, Erin Jamula, Richard Cook, Nancy M. Heddle, Alan Tinmouth, Michelle P. Zeller, Guillaume Beaudoin-Bussières, Luiz Amorim, Renée Bazin, Kent Cadogan Loftsgard, Richard Carl, Michaël Chassé, Melissa M. Cushing, Nick Daneman, Dana V. Devine, Jeannot Dumaresq, Dean A. Fergusson, Caroline Gabe, Marshall J. Glesby, Na Li, Yang Liu, Allison McGeer, Nancy Robitaille, Bruce S. Sachais, Damon C. Scales, Lisa Schwartz, Nadine Shehata, Alexis F. Turgeon, Heidi Wood, Ryan Zarychanski, Andrés Finzi, View ORCID ProfileDonald M. Arnold, for The CONCOR-1 Study Group
doi: https://doi.org/10.1101/2021.06.29.21259427
1Section of Allergy, Immunology and Rheumatology, Department of Pediatrics, CHU Sainte-Justine, Montréal, Québec, Canada
Philippe Bégin
1Section of Allergy, Immunology and Rheumatology, Department of Pediatrics, CHU Sainte-Justine, Montréal, Québec, Canada
2Department of Medicine, Centre Hospitalier de l’Université de Montréal, Montréal, Québec, Canada
MD, PhDJeannie Callum
3Department of Pathology and Molecular Medicine, Kingston Health Sciences Centre and Queen’s University, Kingston, Ontario, Canada
4Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
5Canadian Blood Services, Ottawa, Ontario, Canada
MDErin Jamula
8McMaster Centre for Transfusion Research, McMaster University, Hamilton, Ontario, Canada
Richard Cook
6Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, Ontario, Canada
PhDNancy M. Heddle
5Canadian Blood Services, Ottawa, Ontario, Canada
7Department of Medicine, McMaster University, Hamilton, Ontario, Canada
8McMaster Centre for Transfusion Research, McMaster University, Hamilton, Ontario, Canada
MScAlan Tinmouth
5Canadian Blood Services, Ottawa, Ontario, Canada
9Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada
10Ottawa Hospital Centre for Transfusion Research, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
MDMichelle P. Zeller
5Canadian Blood Services, Ottawa, Ontario, Canada
7Department of Medicine, McMaster University, Hamilton, Ontario, Canada
8McMaster Centre for Transfusion Research, McMaster University, Hamilton, Ontario, Canada
MDGuillaume Beaudoin-Bussières
11Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montréal, Québec, Canada
12CHUM Research Center, Montréal, Québec, Canada
PhDLuiz Amorim
13Hemorio, Rio de Janeiro, Brazil
MDRenée Bazin
14Héma-Québec, Medical Affairs and Innovation, Québec City, Québec, Canada
PhDKent Cadogan Loftsgard
15Community Advisory Committee representative
Richard Carl
16Patient representative
Michaël Chassé
17Innovation Hub, Centre de Recherche du Centre Hospitalier de l’Université de Montréal, Montréal, Québec, Canada
18Department of Medicine (Critical Care), Centre Hospitalier de l’Université de Montréal (CHUM), Montréal, Québec, Canada
MD, PhDMelissa M. Cushing
19Transfusion Medicine and Cellular Therapy, New York-Presbyterian, New York, NY, USA
20Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA
MDNick Daneman
21Department of Medicine, Division of Infectious Diseases, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada
MDDana V. Devine
22Canadian Blood Services, Vancouver, British Columbia, Canada
23Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver British Columbia, Canada
PhDJeannot Dumaresq
24Département de médecine, CISSS de Chaudière-Appalaches, Lévis, Québec, Canada
25Département de microbiologie-infectiologie et d’immunologie, Faculté de Médecine, Université Laval, Québec, Québec, Canada
MDDean A. Fergusson
5Canadian Blood Services, Ottawa, Ontario, Canada
9Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada
26Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
PhDCaroline Gabe
8McMaster Centre for Transfusion Research, McMaster University, Hamilton, Ontario, Canada
MDMarshall J. Glesby
27Division of Infectious Diseases, Weill Cornell Medical College, New York, NY, USA
MD, PhDNa Li
8McMaster Centre for Transfusion Research, McMaster University, Hamilton, Ontario, Canada
28Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada
29Department of Computing and Software, McMaster University, Hamilton, Ontario, Canada
PhDYang Liu
8McMaster Centre for Transfusion Research, McMaster University, Hamilton, Ontario, Canada
MMathAllison McGeer
30Department of Microbiology, Sinai Health System, Toronto, Ontario, Canada
31Department of Laboratory Medicine and Pathobiology and Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
MDNancy Robitaille
32Héma-Québec, Montréal, Québec, Canada
33Division of Hematology and Oncology, Department of Pediatrics, CHU Sainte-Justine, Montréal, Québec, Canada
34Department of Pediatrics, Université de Montréal, Montréal, Québec, Canada
MDBruce S. Sachais
20Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA
35New York Blood Center Enterprises, New York, NY, USA
MD, PhDDamon C. Scales
36Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
37Department of Medicine, Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Ontario, Canada
MD, PhDLisa Schwartz
38Department of Health Research Methods, Evidence & Impact, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada
PhDNadine Shehata
5Canadian Blood Services, Ottawa, Ontario, Canada
39Departments of Medicine, Laboratory Medicine and Pathobiology, Institute of Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada
40Division of Hematology, Mount Sinai Hospital, Toronto, Ontario, Canada
MDAlexis F. Turgeon
41Department of Anesthesiology and Critical Care Medicine, Division of Critical Care Medicine, Faculty of Medicine, Université Laval, Québec City, Québec, Canada
42CHU de Québec – Université Laval Research Centre, Population Health and Optimal Health Practices Research Unit, Trauma-Emergency - Critical Care Medicine, Université Laval, Québec City, Québec, Canada
MD, MScHeidi Wood
43Zoonotic Diseases and Special Pathogens, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada
PhDRyan Zarychanski
44Department of Internal Medicine, Sections of Hematology/Medical Oncology and Critical Care, University of Manitoba, Winnipeg, Manitoba, Canada
MD, MScAndrés Finzi
11Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montréal, Québec, Canada
12CHUM Research Center, Montréal, Québec, Canada
PhDDonald M. Arnold
7Department of Medicine, McMaster University, Hamilton, Ontario, Canada
8McMaster Centre for Transfusion Research, McMaster University, Hamilton, Ontario, Canada
MD, MSc
Article usage
Posted July 03, 2021.
Convalescent plasma for hospitalized patients with COVID-19 and the effect of plasma antibodies: a randomized controlled, open-label trial
The CONCOR-1 Study Group, CONCOR-1 writing committee, Philippe Bégin, Jeannie Callum, Erin Jamula, Richard Cook, Nancy M. Heddle, Alan Tinmouth, Michelle P. Zeller, Guillaume Beaudoin-Bussières, Luiz Amorim, Renée Bazin, Kent Cadogan Loftsgard, Richard Carl, Michaël Chassé, Melissa M. Cushing, Nick Daneman, Dana V. Devine, Jeannot Dumaresq, Dean A. Fergusson, Caroline Gabe, Marshall J. Glesby, Na Li, Yang Liu, Allison McGeer, Nancy Robitaille, Bruce S. Sachais, Damon C. Scales, Lisa Schwartz, Nadine Shehata, Alexis F. Turgeon, Heidi Wood, Ryan Zarychanski, Andrés Finzi, Donald M. Arnold, for The CONCOR-1 Study Group
medRxiv 2021.06.29.21259427; doi: https://doi.org/10.1101/2021.06.29.21259427
Convalescent plasma for hospitalized patients with COVID-19 and the effect of plasma antibodies: a randomized controlled, open-label trial
The CONCOR-1 Study Group, CONCOR-1 writing committee, Philippe Bégin, Jeannie Callum, Erin Jamula, Richard Cook, Nancy M. Heddle, Alan Tinmouth, Michelle P. Zeller, Guillaume Beaudoin-Bussières, Luiz Amorim, Renée Bazin, Kent Cadogan Loftsgard, Richard Carl, Michaël Chassé, Melissa M. Cushing, Nick Daneman, Dana V. Devine, Jeannot Dumaresq, Dean A. Fergusson, Caroline Gabe, Marshall J. Glesby, Na Li, Yang Liu, Allison McGeer, Nancy Robitaille, Bruce S. Sachais, Damon C. Scales, Lisa Schwartz, Nadine Shehata, Alexis F. Turgeon, Heidi Wood, Ryan Zarychanski, Andrés Finzi, Donald M. Arnold, for The CONCOR-1 Study Group
medRxiv 2021.06.29.21259427; doi: https://doi.org/10.1101/2021.06.29.21259427
Subject Area
Subject Areas
- Addiction Medicine (404)
- Allergy and Immunology (713)
- Anesthesia (208)
- Cardiovascular Medicine (2973)
- Dermatology (254)
- Emergency Medicine (446)
- Epidemiology (12828)
- Forensic Medicine (12)
- Gastroenterology (834)
- Genetic and Genomic Medicine (4627)
- Geriatric Medicine (424)
- Health Economics (733)
- Health Informatics (2946)
- Health Policy (1074)
- Hematology (394)
- HIV/AIDS (935)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (476)
- Neurology (4423)
- Nursing (238)
- Nutrition (653)
- Oncology (2299)
- Ophthalmology (654)
- Orthopedics (260)
- Otolaryngology (327)
- Pain Medicine (284)
- Palliative Medicine (85)
- Pathology (503)
- Pediatrics (1201)
- Primary Care Research (503)
- Public and Global Health (7014)
- Radiology and Imaging (1551)
- Respiratory Medicine (923)
- Rheumatology (446)
- Sports Medicine (386)
- Surgery (491)
- Toxicology (60)
- Transplantation (213)
- Urology (185)